|
1
|
Service FJ, McMahon MM, O'Brien PC and
Ballard DJ: Functioning insulinoma-incidence, recurrence, and
long-term survival of patients: A 60-year study. Mayo Clin Proc.
66:711–719. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hirshberg B, Livi A, Bartlett DL, Libutti
SK, Alexander HR, Doppman JL, Skarulis MC and Gorden P:
Forty-eight-hour fast: The diagnostic test for insulinoma. J Clin
Endocrinol Metab. 85:3222–3226. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sarmiento JM, Que FG, Grant CS, Thompson
GB, Farnell MB and Nagorney DM: Concurrent resections of pancreatic
islet cell cancers with synchronous hepatic metastases: Outcomes of
an aggressive approach. Surgery. 132:976–982; discussion 982–983.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Danforth DN Jr, Gorden P and Brennan MF:
Metastatic insulin-secreting carcinoma of the pancreas: Clinical
course and the role of surgery. Surgery. 96:1027–1037.
1984.PubMed/NCBI
|
|
5
|
Hirshberg B, Cochran C, Skarulis MC,
Libutti SK, Alexander HR, Wood BJ, Chang R, Kleiner DE and Gorden
P: Malignant insulinoma: Spectrum of unusual clinical features.
Cancer. 104:264–272. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
La Rosa S, Pariani D, Calandra C, Marando
A, Sessa F, Cortese F and Capella C: Ectopic duodenal insulinoma: A
very rare and challenging tumor type. Description of a case and
review of the literature. Endocr Pathol. 24:213–219. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stefanini P, Carboni M, Patrassi N and
Basoli A: Beta-islet cell tumors of the pancreas: Results of a
study on 1,067 cases. Surgery. 75:597–609. 1974.PubMed/NCBI
|
|
8
|
Haugvik SP, Marangos IP, Røsok BI,
Pomianowska E, Gladhaug IP, Mathisen O and Edwin B: Long-term
outcome of laparoscopic surgery for pancreatic neuroendocrine
tumors. World J Surg. 37:582–590. 2013. View Article : Google Scholar
|
|
9
|
Jonkers YM, Ramaekers FC and Speel EJ:
Molecular alterations during insulinoma tumorigenesis. Biochim
Biophys Acta. 1775:313–332. 2007.PubMed/NCBI
|
|
10
|
Capurso G, Festa S, Valente R, Piciucchi
M, Panzuto F, Jensen RT and Delle Fave G: Molecular pathology and
genetics of pancreatic endocrine tumours. J Mol Endocrinol.
49:R37–R50. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Speel EJ, Scheidweiler AF, Zhao J, Matter
C, Saremaslani P, Roth J, Heitz PU and Komminoth P: Genetic
evidence for early divergence of small functioning and
nonfunctioning endocrine pancreatic tumors: Gain of 9Q34 is an
early event in insulinomas. Cancer Res. 61:5186–5192.
2001.PubMed/NCBI
|
|
12
|
Jonkers YM, Claessen SM, Feuth T, van
Kessel AG, Ramaekers FC, Veltman JA and Speel EJ: Novel candidate
tumour suppressor gene loci on chromosomes 11q23-24 and 22q13
involved in human insulinoma tumourigenesis. J Pathol. 210:450–458.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jonkers YM, Claessen SM, Perren A, Schmid
S, Komminoth P, Verhofstad AA, Hofland LJ, de Krijger RR, Slootweg
PJ, Ramaekers FC, et al: Chromosomal instability predicts
metastatic disease in patients with insulinomas. Endocr Relat
Cancer. 12:435–447. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Speel EJ, Richter J, Moch H, Egenter C,
Saremaslani P, Rütimann K, Zhao J, Barghorn A, Roth J, Heitz PU, et
al: Genetic differences in endocrine pancreatic tumor subtypes
detected by comparative genomic hybridization. Am J Pathol.
155:1787–1794. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chung DC, Brown SB, Graeme-Cook F,
Tillotson LG, Warshaw AL, Jensen RT and Arnold A: Localization of
putative tumor suppressor loci by genome-wide allelotyping in human
pancreatic endocrine tumors. Cancer Res. 58:3706–3711.
1998.PubMed/NCBI
|
|
16
|
Stumpf E, Aalto Y, Höög A, Kjellman M,
Otonkoski T, Knuutila S and Andersson LC: Chromosomal alterations
in human pancreatic endocrine tumors. Genes Chromosomes Cancer.
29:83–87. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao J, Moch H, Scheidweiler AF, Baer A,
Schäffer AA, Speel EJ, Roth J, Heitz PU and Komminoth P: Genomic
imbalances in the progression of endocrine pancreatic tumors. Genes
Chromosomes Cancer. 32:364–372. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Capdeville R, Buchdunger E, Zimmermann J
and Matter A: Glivec (STI571, imatinib), a rationally developed,
targeted anticancer drug. Nat Rev Drug Discov. 1:493–502. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Haugvik SP, Gorunova L, Haugom L, Eibak
AM, Gladhaug IP, Heim S and Micci F: Loss of 11p11 is a frequent
and early event in sporadic nonfunctioning pancreatic
neuroendocrine neoplasms. Oncol Rep. 32:906–912. 2014.PubMed/NCBI
|
|
20
|
Ge H, Liu K, Juan T, Fang F, Newman M and
Hoeck W: FusionMap: Detecting fusion genes from next-generation
sequencing data at base-pair resolution. Bioinformatics.
27:1922–1928. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCTmethod. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
22
|
Monk D, Sanches R, Arnaud P, Apostolidou
S, Hills FA, Abu-Amero S, Murrell A, Friess H, Reik W, Stanier P,
et al: Imprinting of IGF2 P0 transcript and novel alternatively
spliced INS-IGF2 isoforms show differences between mouse and human.
Hum Mol Genet. 15:1259–1269. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Minn AH, Kayton M, Lorang D, Hoffmann SC,
Harlan DM, Libutti SK and Shalev A: Insulinomas and expression of
an insulin splice variant. Lancet. 363:363–367. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoshimoto M, Joshua AM, Chilton-Macneill
S, Bayani J, Selvarajah S, Evans AJ, Zielenska M and Squire JA:
Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer
indicates that genomic microdeletion of chromosome 21 is associated
with rearrangement. Neoplasia. 8:465–469. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rickman DS, Pflueger D, Moss B, VanDoren
VE, Chen CX, de la Taille A, Kuefer R, Tewari AK, Setlur SR,
Demichelis F, et al: SLC45A3-ELK4 is a novel and frequent
erythroblast transformation-specific fusion transcript in prostate
cancer. Cancer Res. 69:2734–2738. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Gong M, Yuan H, Park HG, Frierson
HF and Li H: Chimeric transcript generated by cis-splicing of
adjacent genes regulates prostate cancer cell proliferation. Cancer
Discov. 2:598–607. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Prakash T, Sharma VK, Adati N, Ozawa R,
Kumar N, Nishida Y, Fujikake T, Takeda T and Taylor TD: Expression
of conjoined genes: Another mechanism for gene regulation in
eukaryotes. PLoS One. 5:e132842010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Berger MF, Levin JZ, Vijayendran K,
Sivachenko A, Adiconis X, Maguire J, Johnson LA, Robinson J,
Verhaak RG, Sougnez C, et al: Integrative analysis of the melanoma
transcriptome. Genome Res. 20:413–427. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wernersson R, Frogne T, Rescan C, Hansson
L, Bruun C, Grønborg M, Jensen JN and Madsen OD: Analysis artefacts
of the INS-IGF2 fusion transcript. BMC Mol Biol. 16:132015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kanatsuna N, Taneera J, Vaziri-Sani F,
Wierup N, Larsson HE, Delli A, Skärstrand H, Balhuizen A, Bennet H,
Steiner DF, et al: Autoimmunity against INS-IGF2 protein expressed
in human pancreatic islets. J Biol Chem. 288:29013–29023. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kanatsuna N, Delli A, Andersson C, Nilsson
AL, Vaziri-Sani F, Larsson K, Carlsson A, Cedervall E, Jönsson B,
Neiderud J, et al: Doubly reactive INS-IGF2 autoantibodies in
children with newly diagnosed autoimmune (type 1) diabetes. Scand J
Immunol. 82:361–369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Skyler JS: Immune intervention for type 1
diabetes mellitus. Int J Clin Pract Suppl. 65:61–70. 2011.
View Article : Google Scholar
|
|
33
|
Moser A, Hsu HT and van Endert P: Beta
cell antigens in type 1 diabetes: Triggers in pathogenesis and
therapeutic targets. F1000 Biol Rep. 2:752010.PubMed/NCBI
|
|
34
|
Nica AC, Ongen H, Irminger JC, Bosco D,
Berney T, Antonarakis SE, Halban PA and Dermitzakis ET: Cell-type,
allelic, and genetic signatures in the human pancreatic beta cell
transcriptome. Genome Res. 23:1554–1562. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim RN, Kim A, Choi SH, Kim DS, Nam SH,
Kim DW, Kim DW, Kang A, Kim MY, Park KH, et al: Novel mechanism of
conjoined gene formation in the human genome. Funct Integr
Genomics. 12:45–61. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kralovicova J and Vorechovsky I:
Allele-specific recognition of the 3′ splice site of INS intron 1.
Hum Genet. 128:383–400. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fradin D, Le Fur S, Mille C, Naoui N,
Groves C, Zelenika D, McCarthy MI, Lathrop M and Bougnères P:
Association of the CpG methylation pattern of the proximal insulin
gene promoter with type 1 diabetes. PLoS One. 7:e362782012.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lempainen J, Härkönen T, Laine A, Knip M
and Ilonen J: Finnish Pediatric Diabetes Register: Associations of
polymorphisms in non-HLA loci with autoantibodies at the diagnosis
of type 1 diabetes: INS and IKZF4 associate with insulin
autoantibodies. Pediatr Diabetes. 14:490–496. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dejeux E, Olaso R, Dousset B, Audebourg A,
Gut IG, Terris B and Tost J: Hypermethylation of the IGF2
differentially methylated region 2 is a specific event in
insulinomas leading to loss-of-imprinting and overexpression.
Endocr Relat Cancer. 16:939–952. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chung DC, Brown SB, Graeme-Cook F, Seto M,
Warshaw AL, Jensen RT and Arnold A: Overexpression of cyclin D1
occurs frequently in human pancreatic endocrine tumors. J Clin
Endocrinol Metab. 85:4373–4378. 2000.PubMed/NCBI
|
